Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00103363 · ClinicalTrials.gov registry record · Phase 2

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

A Phase 2 study, sponsored by University of Colorado, Denver.

Completed
Registry status
Phase 2
Development phase
3,270
Enrollment target

NCT00103363: Completed Phase 2 study, sponsored by University of Colorado, Denver.

NCT00103363 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 3,270 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2359% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00103363, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Phase 2
Development phase
3,270 participants
Enrollment target

Study Summary

RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer. PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.

Interventions

  • OTHER cytology specimen collection procedure
  • OTHER physiologic testing
  • PROCEDURE study of high risk factors
  • PROCEDURE annual screening

Trial Details

FieldValue
Enrollment Target 3,270 participants
Start Date 1993-02
Est. Completion 1994-02
Phase Phase 2
University of Colorado, Denver

1,283 total trials

What the finished NCT00103363 record still lists

NCT00103363 is an interventional study that assigns participants to a tested intervention. Its 3,270 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2359% higher).

The record links to 0 conditions, and to 4 interventions - of which cytology specimen collection procedure is the first listed.

NCT00103363 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00103363 about?

NCT00103363 is a clinical study titled "Sputum Cytology in Screening Heavy Smokers For Lung Cancer". RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer. PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.

What is the current status of trial NCT00103363?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 3,270 participants. The study started on 1993-02. Estimated completion is 1994-02.

What interventions are being tested in trial NCT00103363?

The interventions under investigation include: cytology specimen collection procedure (OTHER), physiologic testing (OTHER), study of high risk factors (PROCEDURE), annual screening (PROCEDURE).

Who is sponsoring clinical trial NCT00103363?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00103363's enrollment target sits among peer trials

3,270 6th of 2000 higher than 1,995 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04077762 · 3,266 participants · NA

    Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

  • NCT06543446 · 3,290 participants · NA

    Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  • NCT06953375 · 3,250 participants · NA

    Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty

  • NCT06815536 · 3,291 participants

    Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00103363, the US trial registry maintained by the National Library of Medicine. NCT00103363 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.